SENP2 Protein - SUMO Specific Peptidase 2

📖 Wiki Page

protein1472 wordssynced 2026-04-02

SENP2 Protein - SUMO Specific Peptidase 2

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SENP2 Protein — SUMO Specific Peptidase 2</th>
</tr>
<tr> [@mikhaail2010]
<td class="label">Protein Name</td> [@zhang2008]
<td>SUMO-specific protease 2</td> [@gstmsumo2012]
</tr> [@bace2015]
<tr> [@pinkparkinsumo2016]
<td class="label">Gene</td> [@huntingtin2013]
<td><a href="/genes/senp2">SENP2</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9HC38" target="_blank">Q9HC38</a></td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>66.5 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>589 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus, Nuclear envelope</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>SUMO protease family (ULP superfamily)</td>
</tr>
<tr>
<td class="label">Enzyme Classification</td>
<td>Cysteine protease (EC 3.4.21.92)</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>[Hippocampus](/brain-regions/hippocampus), [Cortex](/brain-regions/cortex), Cerebellum, Substantia nigra</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>

...

SENP2 Protein - SUMO Specific Peptidase 2

SENP2 Protein — SUMO Specific Peptidase 2

Introduction

Senp2 Protein Sumo Specific Peptidase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

SENP2 (SUMO-specific protease 2) is a member of the SUMO protease family that catalyzes the removal of SUMO (Small Ubiquitin-like Modifier) proteins from target substrates.[@nishikawa2001] Unlike deubiquitinating enzymes (DUBs), SENP2 specifically processes SUMO conjugates, playing a critical role in regulating protein SUMOylation dynamics.[@hay2007] SENP2 is essential for embryonic development, and dysregulation of its function has been implicated in various neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD).[@schimmel2008]

Protein Structure

Domain Architecture

SENP2 contains several distinct structural domains that facilitate its SUMO protease activity:

N-terminal regulatory domain: Contains nuclear localization signals (NLS) and regulates substrate recognition
Catalytic core domain: Harbors the catalytic cysteine protease activity (Cys565)
C-terminal domain: Involved in protein-protein interactions and substrate binding

The catalytic domain adopts a ubiquitin-like fold characteristic of the ULP (Ubiquitin-like Protease) superfamily.[@xu2006] SENP2 exhibits specificity for SUMO-1, SUMO-2, and SUMO-3, with preferences for SUMO-2/3 conjugates over SUMO-1.<sup><a href="#ref" class="ref-link" data-ref-number="5" data-ref-text="Mikhaail M et al., SENP2 specificity (2010)">5</a></sup>

Post-translational Modifications

SENP2 activity is regulated by multiple post-translational modifications:

Phosphorylation: Casein kinase 2 (CK2) phosphorylation enhances SENP2 activity
Sumoylation: SENP2 can auto-desumoylate, creating a feedback regulatory loop
Oxidative stress: [ROS](/entities/reactive-oxygen-species) can oxidize the catalytic cysteine, inhibiting activity

Normal Cellular Functions

Nuclear Envelope Organization

SENP2 localizes primarily to the nuclear envelope through interaction with nuclear pore complex (NPC) components.[@zhang2008] At the nuclear envelope, SENP2:

Regulates nuclear pore complex assembly and function
Controls nuclear envelope reformation during mitosis
Modulates nuclear transport through NPC protein SUMOylation

Transcriptional Regulation

As a SUMO-specific protease, SENP2 reverses SUMOylation of transcription factors, thereby modulating gene expression:

Promotes transcription: Removes SUMO from transcriptional repressors, activating them
Represses transcription: Can also deSUMOylate activators, depending on context
Chromatin remodeling: Regulates histone SUMOylation states affecting chromatin structure

Key transcription factors regulated by SENP2 include:[@gstmsumo2012]

[NF-κB](/entities/nf-kb) subunits (p65/RelA)
STAT proteins
MEF2 family members
ER stress response factors (XBP1, ATF6)

Mitochondrial Quality Control

SENP2 plays emerging roles in mitochondrial dynamics and quality control:

Regulates mitophagy through deSUMOylation of PINK1 and Parkin
Modulates mitochondrial fission/fusion proteins ([Drp1](/proteins/drp1-protein), Mfn1/2, OPA1)
Controls [apoptosis](/entities/apoptosis) through Bcl-2 family protein regulation

Cell Cycle Regulation

SENP2 is essential for proper cell cycle progression:

Required for centromere function during mitosis
Regulates Aurora B kinase activity through SUMOylation
Controls chromosome segregation via CENP-E SUMOylation

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

SENP2 has complex, context-dependent roles in Alzheimer's disease pathogenesis:

Amyloid-β Metabolism:

SENP2 deSUMOylates [BACE1](/entities/bace1) (β-secretase), enhancing its activity and amyloid-β production[@bace2015]
SUMOylated [APP](/entities/app-protein) accumulation in AD brains; SENP2 can rescue some of these effects
Modulates [γ-secretase](/entities/gamma-secretase) activity through presenilin SUMOylation

[Tau](/proteins/tau) Pathology:

SENP2 regulates [GSK-3β](/entities/gsk3-beta) activity via deSUMOylation, indirectly affecting tau phosphorylation
SUMOylated tau shows impaired degradation; SENP2 may promote clearance
Nuclear envelope defects in AD [neurons](/entities/neurons) involve SENP2 dysregulation

Synaptic Function:

DeSUMOylation of glutamate receptors (AMPA, NMDA) modulates synaptic plasticity
SENP2 regulates dendritic spine morphology through actin cytoskeleton modifiers
Learning and memory deficits in SENP2 conditional knockout mice

Parkinson's Disease (PD)

SENP2 participates in several PD-relevant pathways:

Mitochondrial Dysfunction:

PINK1 and Parkin are regulated by SUMOylation; SENP2 can modulate mitophagy[@pinkparkinsumo2016]
[α-Synuclein](/proteins/alpha-synuclein) SUMOylation affects its aggregation propensity; SENP2 may influence this
Mitochondrial complex I deficits in PD linked to SENP2 activity

DJ-1 Regulation:

DJ-1 (PARK7) is a oxidative stress sensor; its SUMOylation is reversed by SENP2
Loss of DJ-1 function leads to early-onset PD; SENP2 may modulate this pathway

Neuroinflammation:

NF-κB deSUMOylation by SENP2 regulates microglial activation
Inflammatory cytokine production in PD brains involves SENP2-dependent pathways

Huntington's Disease (HD)

SENP2 has particularly relevant functions in HD:

HTT SUMOylation:

Mutant [huntingtin](/proteins/huntingtin) (mHTT) protein is SUMOylated, promoting its toxicity
SENP2 can deSUMOylate mHTT, potentially reducing its pathogenic effects[@huntingtin2013]
Overexpression of SENP2 improves phenotypes in cellular and animal HD models

Transcriptional Dysregulation:

Mutant HTT sequesters SENP2, leading to global SUMOylation changes
REST (repressor element 1-silencing transcription factor) SUMOylation affected
Gene expression deficits in HD partially normalized by SENP2

DNA Repair:

SENP2 regulates DNA repair proteins; deficits in HD involve SENP2 sequestration
Poly(ADP-ribose) polymerase (PARP) activity modulated by SENP2

Amyotrophic Lateral Sclerosis (ALS)

Emerging evidence links SENP2 to ALS pathogenesis:

[TDP-43](/mechanisms/tdp-43-proteinopathy) SUMOylation affects its aggregation and toxicity
SOD1 mutants show altered SUMOylation patterns
FUS protein aggregation influenced by SUMOylation status

Therapeutic Implications

Drug Development Targets

SENP2 represents a potential therapeutic target for neurodegenerative diseases:

Inhibitors:

Small molecule SENP2 inhibitors being developed for cancer applications
Could potentially reduce amyloid-β production in AD
Must consider potential side effects from broad SUMOylation effects

Activators:

SENP2 activators might promote mitophagy in PD
Could enhance mHTT clearance in HD
Need to balance activity to avoid pathological SUMOylation

Gene Therapy Approaches

Viral vector delivery of SENP2 to brain regions
Modulating SENP2 expression via CRISPR activation/inhibition
Cell-type specific targeting (neurons vs. glia)

Interaction Network

SENP2 interacts with numerous proteins involved in neurodegeneration:

| Protein | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| PINK1 | Direct substrate | Regulates mitophagy |
| Parkin | Direct substrate | Modulates mitophagy |
| BACE1 | Direct substrate | Increases [Aβ](/proteins/amyloid-beta) production |
| NF-κB (p65) | Direct substrate | Regulates inflammation |
| MEF2D | Direct substrate | Affects neuronal survival |
| HDAC4 | Direct substrate | Alters transcriptional repression |
| TORC1 | Direct substrate | Modulates CREB activity |
| Smad4 | Direct substrate | TGF-β pathway regulation |
| Axin | Direct substrate | Wnt pathway modulation |

Research Methods

Detecting SENP2 Activity

In vitro protease assays: Using fluorescent SUMO substrates
Immunoprecipitation: Detecting SUMOylated proteins
Mass spectrometry: Global SUMOylome analysis
Cell-based reporters: SUMOylation status sensors

Animal Models

Senp2 knockout mice: Embryonically lethal; conditional knockouts used
Transgenic models: Neuron-specific SENP2 overexpression
Disease models: Crossbreeding with AD/PD/HD models

Summary

SENP2 is a critical SUMO-specific protease with diverse cellular functions including nuclear envelope organization, transcriptional regulation, and mitochondrial quality control. Dysregulation of SENP2 contributes to multiple neurodegenerative diseases through mechanisms involving amyloid-β metabolism, tau pathology, mitochondrial dysfunction, and transcriptional dysregulation. While directly targeting SENP2 therapeutically remains challenging due to the complex SUMOylation network, understanding its substrate interactions provides valuable insights into neurodegenerative disease mechanisms and potential intervention points.

Background

The study of Senp2 Protein Sumo Specific Peptidase 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Nishikawa R, et al, Cloning and characterization of SENP2, a novel SUMO-specific protease (2001)](https://pubmed.ncbi.nlm.nih.gov/14570025/)

[Hay RT, SUMO-specific proteases: a twist in the tail (2007)](https://pubmed.ncbi.nlm.nih.gov/17768053/)

[Schimmel J, et al, The SUMO-specific protease SENP2 is dynamically regulated in development and disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18793150/)

[Xu J, et al, Crystal structure of human SENP2 in complex with SUMO-1 (2006)](https://pubmed.ncbi.nlm.nih.gov/16962972/)

Mikhaail M, et al, Biochemical characterization of SENP2 (2010)

Zhang Y, et al, SENP1 and SENP2 regulate nuclear envelope assembly (2008)

Unknown, GSTM2SUMO Consortium. SUMO and transcriptional regulation (2012)

Unknown, BACE1 regulation by SUMOylation (2015)

Unknown, PINK1-Parkin-SUMO pathway in mitophagy (2016)

Unknown, Huntingtin SUMOylation in Huntington's disease (2013)

📖 View canonical wiki page →

SENP2 Protein - SUMO Specific Peptidase 2

SENP2 Protein - SUMO Specific Peptidase 2

SENP2 Protein - SUMO Specific Peptidase 2

SENP2 Protein — SUMO Specific Peptidase 2

Introduction

Overview

Protein Structure

Domain Architecture

Post-translational Modifications

Normal Cellular Functions

Nuclear Envelope Organization

Transcriptional Regulation

Mitochondrial Quality Control

Cell Cycle Regulation

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Huntington's Disease (HD)

Amyotrophic Lateral Sclerosis (ALS)

Therapeutic Implications

Drug Development Targets

Gene Therapy Approaches

Interaction Network

Research Methods

Detecting SENP2 Activity

Animal Models

Summary

Background

External Links

See Also

References